Studies on the preparation, characterization, and solubility of 2-HP-β-cyclodextrin-meclizine hcl inclusion complexes

Journal of Young Pharmacists

Volumn 4, Issue 4, 2012, Pages 220-227

  George, S J ^a   Vasudevan, D T ^a  

^a AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

2 Hydroxypropyl cyclodextrin; co precipitation method; kneading method; Meclizine HCl; phase solubility profile; cyclodextrin

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; BETA CYCLODEXTRIN; MECLOZINE;

ARTICLE; COMPARATIVE STUDY; COMPLEX FORMATION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DOSAGE FORM COMPARISON; DRUG MIXTURE; DRUG RELEASE; DRUG SOLUBILITY; DRUG SYNTHESIS; IN VITRO STUDY; INCLUSION COMPLEXATION; INFRARED SPECTROSCOPY; POWDER; PRECIPITATION; PRIORITY JOURNAL; STOICHIOMETRY; TABLET COMPRESSION; TABLET FORMULATION;

EID: 84872135040     PISSN: 09751483     EISSN: 09751505     Source Type: Journal    
DOI: 10.4103/0975-1483.104365     Document Type: Article

References (32)

1. Oosterveld WJ. Vertigo: Current concepts in management. Drugs 1985;30:275-83.
2. MHCL. Available from: http:\\www.drugbank.com. [Last accessed on 2011 Oct 25].
3. The Pharmaceutical Codex. 11th ed. Pharmaceutical Society of Great Britain; 1979. p. 518.
4. Jain NK. Progress in controlled and novel drug delivery system. Drug Deliv Syst 2004;1:384-400.
5. Loftson T, Brewster ME. Pharmaceutical applications of cyclodextrins, drug solubilization and stabilization. J Pharm Sci 1996;59:1601-8.
6. Duchene D, Wouessidjewe D. Physiochemical characteristics and pharmaceutical uses of cyclodextrin derivatives, Part II. Pharm Technol 1990;14:26-34.
7. Challa R, Ahuja A, Ali J, Khar R. Cyclodextrins in drug delivery: An updated review. AAPS PharmSciTech 2005;6:329-57.
8. Carrier RL, Miller LA, Ahmed I. The utility of cyclodextrins for enhancing oral bioavailability. J Control Rel 2007;123:78-99.
9. Odak SP, Gidwani SK. Enhancement of aqueous solubility of levodopa by using 2-HP-ß-cyclodextrin. Int J Pharm Sci 2011;3:933-8.
10. Ahmed MO. Comparison of impact of the different hydrophilic carriers on the properties of piperazine-containing drug. Eur J Pharm Biopharm 2001;51:221-6.
11. Pose-Vilarnovo B, Perdomo-López I, Echezarreta-López M, Schroth-Pardo P, Estrada E, Torres-Labandeira JJ. Improvement of water solubilityof sulfamethizole through its complexation with ß-and Hydroxypropyl-ß-cyclodextrin Characterization of the interaction in solution and in solid state. Eur J Pharm Sci 2001;13:325-31.
12. Maski N, Kumaran A, Girhepunje K, Ghode P, Randive S, Pal R. Studies on the preparation, characterization and solubility of ß-cyclodextrin- diacerein inclusion complexes. Int J Pharm Pharm Sci 2009;1:121-35.
13. Zeng J, Ren Y, Zhou C, Yu S, Chen WH. Preparation and physicochemical characteristics of the complex of edaravone with Hydroxypropyl-ß- cyclodextrin. Carbohy Dr. Polym 2011;83:1101-5.
14. Ling W, Xuehua J, Weijuan X, Chenrui L. Complexation of Tanshinone IIA with 2-hydroxypropyl-ß-cyclodextrin: Effect on aqueous solubility, dissolution rate, and intestinal absorption behaviour in rats. Int J Pharm 2007;341:58-67.
15. Derle D, Boddu SH, Mager M. Studies on the preparation, characterization and solubility of ß-cyclodextrin-starnidazole inclusion complexes. Indian J Pharma Educ Res 2006;40:232-6.
16. Baboota S, Dhariwal M, Kohli K. Physicochemical charactrization, in vitro dissolution behaviour and phamacodynamic studies of refecoxibcyclodextrin inclusion compound. Preparation and properties of refecoxib hydroxypropyl ß-cyclodextrin inclusion complex. AAPS Pharma Sci Tech 2005;6:83-90.
17. Manca ML, Zaru M, Ennas G, Valenti D, Sinico C, Lov G, et al. Diclofenac -ß-cyclodextrin binary system: Physicochemical characterization and invitrodissolution and diffusion studies. AAPS PharmaSciTech 2005;6:464-72.
18. Higuchi T, Connors KA. Phase solubility techniques. Adv Anal Chem Instrum 1965;4:117-212.
19. Higuchi T, Kristiansen H. Binding specificity between small organic solutes in aqueous solution, classification of some solutes into two groups according to binding tendencies. J Pharm Sci 1970;59:1601-8.
20. Zughul MB, Badwan AA. Rigorous analysis of S2L-type phase solubility diagrams to obtain individual formation and solubility product constants of both SL-and S2L-type complexes. Int J Pharm 1997;151:109-19.
21. Marques HC, Hadgraft J, Kllaway I. Studies of cyclodextrin inclusion complexes; The salbutamol-cyclodextrin complex as studies by phasesolubility and DSC. Int J Pharm 1990;63:259-60.
22. Tirucherai GS, Mitra AK. Effect of hydroxypropyl beta cyclodextrin complexation on aqueous solubility, stability, and corneal permeation of acyl ester prodrugs of ganciclovir. AAPS PharmSciTech 2003;45:1-12.
23. Klancke J. Dissolution testing of orally disintegrating tablets. Dissolution Technol 2003:1 6-8.
24. Patil PB, Gupta VR, Udupi RH, Srikanth K, Prasad BS. Development of dissolution medium for poorly water soluble drug mefenamic acid. Research Journal of Pharmaceutical, Biological and Chemical Sciences 2010;1:544-9.
25. Singla N, Gupta GD, Kohli K, Singla AK. A discriminatory and biorelevant dissolution test method for simvastatin drug products. Dissolution Technol 2009;3:11-13.
26. Jain CP, Naruka PS. Formulation and evaluation of fast dissolving tablets of alsartan. Int J Pharm Pharm Sci 2009;1:219-26.
27. Patel B, Patel D, Parmar R, Patel C, Serasiya T, Sanja SD. Development and in vitro evaluation of fast dissolving tablets of glipizide. Int J Pharm Pharm Sci 2009;1:145-50.
28. Miyazawa I, Ueda H, Nagase H, Endo T, Kobayashi S, Nagai T. Physicochemical properties and inclusion complex formation of d-cyclodextrin. Eur J Pharm Sci 1995;3:153-62.
29. Chowdhery KP, Vijaya SS. Effect of polyvinylpyrrolidone on complexation and dissolution rate of ß-cyclodextrin and hydroxypropyl ß-cyclodextrin complexes of celecoxib. Indian J Pharm Sci 2006;68:631-4.
30. Giordano F, Novak C, Moyano Jr. Thermal analysis of cyclodextrins and their inclusion compounds. Thermochim Acta 2001;380:123-51.
31. Veiga F, Fernandes C, Maincent P. Influence of the preparation method on the physicochemical properties of tolbutamide/cyclodextrin binary system. Drug Dev Ind Pharm 2001;27:523-32.
32. Varia U, Patil C, Kalyane N, Agrawal P. Effect of cyclodextrin inclusion complex on dissolution behaviour of cefixime. J Pharm Res 2010;3:570-4.